NICE backs NHS funding for two cannabis-based drugs for first timeNICE has recommended two of GW Pharma’s cannabis-based medicines, the first time that medicines derived from the plant Share XNICE backs NHS funding for two cannabis-based drugs for first timehttps://pharmaphorum.com/news/nice-includes-bayer-gws-cannabis-based-sativex-in-ms-guideline-for-first-time/
GW launches cannabis-based epilepsy drug in USGW Pharmaceuticals is bullish about the company’s prospects following the launch of its cannabis-based medicine for a rare Share XGW launches cannabis-based epilepsy drug in UShttps://pharmaphorum.com/news/gw-launches-cannabis-based-epilepsy-drug-in-us/
